Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve i) Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30-Sep-2026; ii) consider and approve proposal for raising of funds and other ancillary functions, subject to such statutory and regulatory approvals as may be necessary.

TUDARTHAII PHAR]IA IIIDUOTRIES tTD Head Otfice : 301 Aura Biplex Premilm Retai Premises, 7, S.V Road, Borival (West), Murnba '400092 E-mail : comp iance@sudarshanphanna com Website : www.s!darshanpharma com sPL/CS /SE /2026-2027 /70 Date: 25tr, October 2026 The Listing Department BSE Limited I3SE Scrip Codc: 543828 Phir oze Jeejeebhol Tou,crs, BSE Trading Svmbol: SUDARSHAN Dalal Streei, Nlumlrai ,100 001 lSlN:1NE0(lIV01tl23 Dear Sir/N{adam, Sub: Meeting of the Board of Dtuectors of the Company scheduled to be held on Thursday, 29ft October, 2026 liursuant to Regul.riion 29 of SEBI (Listint Obligations and Disclosure llequilcments) Ilcgulations, 2015, l'e u,ish lo inform 1'ou that a meeting of the Board of Directors o{ the Compilny is schcrlulccl to be held on Thursclay, 29tL Ociober', 2026, inter alia, to: 1) consiclcl anLl applo\,e lhc Unauclitccl Stanclalone & Consoliclated Finar-rcial Rcsults of the Cornpan," for the quarter and half t,eal endeci 30d. September, 202(,. 2) cousiclcr antl applole ploposal 1u- raising of tuncls bv u,al oi issue ot one or nrore oi instl Llments comprisiDg ot el-iuit\. shares, convertible securities of anv othel des.l_iPtion or \'!,nrrants or debt securities, through Prir-atc Placement / Pleferential lssue / Qualiliecl Iltstitutions Placernent or such other methods or conbinations thercof aucl to appr'ove ancilian actions for.the above mentioned tuncl raisin,.l, subject to such statulory / rcgulatory approvals as [ray be n,la,1s<,- 4'' Fulthcr, please note that thc Trading Wilclor,r, of the Company shall continue to l L,main closed ulttil the elpir'\, of :18 houls after.the cleclaration of the financial results fol the qualtcl ancl half enclccl30th September,2026. 1,ear Request you to take the sarne on record. Thanks & Regards, For, Sudarshan Pharma $w ((\a Nir;n, Shah (on1pan\. Sccretary & Conlp Regd. Otl. : 301, Aura Biplex, Above Kalyan Jewellers, S,V Road, Borivali (West), l\,4umbai - 400092,